Tumor-infiltrating lymphocytes for adoptive cell therapy
US12291724B2 · kind B2 · utility
0Cited by
10References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 24, 2022 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Oct 10, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/999
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions and methods for ex vivo expansion of tumor infiltrating lymphocytes for use in adoptive cell therapy (ACT). Also disclosed are compositions and method for identifying an agent for ex vivo expansion of tumor infiltrating lymphocytes for use in ACT. Also disclosed are methods for treating cancer using tumor-infiltrating lymphocytes expanded by the disclosed methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.